» Articles » PMID: 20176575

Attenuated Variants of Lesch-Nyhan Disease

Abstract

Lesch-Nyhan disease is a neurogenetic disorder caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase. The classic form of the disease is described by a characteristic syndrome that includes overproduction of uric acid, severe generalized dystonia, cognitive disability and self-injurious behaviour. In addition to the classic disease, variant forms of the disease occur wherein some clinical features are absent or unusually mild. The current studies provide the results of a prospective and multi-centre international study focusing on neurological manifestations of the largest cohort of Lesch-Nyhan disease variants evaluated to date, with 46 patients from 3 to 65 years of age coming from 34 families. All had evidence for overproduction of uric acid. Motor abnormalities were evident in 42 (91%), ranging from subtle clumsiness to severely disabling generalized dystonia. Cognitive function was affected in 31 (67%) but it was never severe. Though none exhibited self-injurious behaviours, many exhibited behaviours that were maladaptive. Only three patients had no evidence of neurological dysfunction. Our results were compared with a comprehensive review of 78 prior reports describing a total of 127 Lesch-Nyhan disease variants. Together these results define the spectrum of clinical features associated with hypoxanthine-guanine phosphoribosyltransferase deficiency. At one end of the spectrum are patients with classic Lesch-Nyhan disease and the full clinical phenotype. At the other end of the spectrum are patients with overproduction of uric acid but no apparent neurological or behavioural deficits. Inbetween are patients with varying degrees of motor, cognitive, or behavioural abnormalities. Recognition of this spectrum is valuable for understanding the pathogenesis and diagnosis of all forms of hypoxanthine-guanine phosphoribosyltransferase deficiency.

Citing Articles

Whole Exome Sequencing Facilitates Early Diagnosis of Lesch-Nyhan Syndrome: A Case Series.

Fang H, Lee C, Chen H, Chuang C, Chiu H, Chang Y Diagnostics (Basel). 2025; 14(24.

PMID: 39767170 PMC: 11675658. DOI: 10.3390/diagnostics14242809.


Metabolic and neurobehavioral disturbances induced by purine recycling deficiency in .

Petitgas C, Seugnet L, Dulac A, Matassi G, Mteyrek A, Fima R Elife. 2024; 12.

PMID: 38700995 PMC: 11068357. DOI: 10.7554/eLife.88510.


Psychiatric Manifestations in Children and Adolescents with Inherited Metabolic Diseases.

Baglioni V, Bozza F, Lentini G, Beatrice A, Cameli N, Cinnante E J Clin Med. 2024; 13(8).

PMID: 38673463 PMC: 11051134. DOI: 10.3390/jcm13082190.


A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts.

Escudero-Ferruz P, Ontiveros N, Cano-Estrada C, Sutcliffe D, Jinnah H, Torres R Mol Med. 2024; 30(1):3.

PMID: 38172668 PMC: 10765874. DOI: 10.1186/s10020-023-00774-8.


Single-Electrode Deep Brain Stimulation of Bilateral Posterolateral Globus Pallidus Internus in Patients With Medically Resistant Lesch-Nyhan Syndrome.

Baird-Daniel E, Glaser A, Boop S, Durfy S, Hauptman J Cureus. 2023; 15(4):e37070.

PMID: 37153246 PMC: 10155820. DOI: 10.7759/cureus.37070.


References
1.
Yeh J, Zheng S, Howard B . Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome. J Neurosci Res. 1998; 53(1):78-85. DOI: 10.1002/(SICI)1097-4547(19980701)53:1<78::AID-JNR8>3.0.CO;2-G. View

2.
GEERDINK R, de Vries W, Willemse J, Oei T, de Bruyn C . An atypical case of hypoxanthine-guanine phosphoribosyltransferase deficiency (Lesch-Nyhan syndrome). I. Clinical studies. Clin Genet. 1973; 4(4):348-52. DOI: 10.1111/j.1399-0004.1973.tb01930.x. View

3.
MARCUS S, Christensen E, Malm G . Molecular analysis of the mutations in five unrelated patients with the Lesch Nyhan syndrome. Hum Mutat. 1993; 2(6):473-7. DOI: 10.1002/humu.1380020608. View

4.
Wong D, Harris J, Naidu S, Yokoi F, Marenco S, Dannals R . Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci U S A. 1996; 93(11):5539-43. PMC: 39282. DOI: 10.1073/pnas.93.11.5539. View

5.
Adler C, Wrabetz L . Lesch-Nyhan variant: dystonia, ataxia, near-normal intelligence, and no self-mutilation. Mov Disord. 1996; 11(5):583-4. DOI: 10.1002/mds.870110519. View